PLYX · Polaryx Therapeutics, Inc. · Investor Relations
$1.82
-0.03 (-1.62%)
At close · Oct 26
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These matters, along with the conditions described above, raise substantial doubt about the Company's ability to continue as a going concern for a period of twelve months from the date these financial statements were available to be issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$92.22M
Shares
49.85M
Volume · Oct 26
27.52K
Avg daily vol (3M)
65.49K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-04-16 | 25th Annual Needham Virtual Healthcare Conference | Conference |
Source: https://investors.polaryx.com/